JNJJohnson & Johnson
Johnson & Johnson (JNJ) is a equity covered by Valdrans. Last close $261.44, +1.93% on the day; +2.11% over 1 week, -1.56% over 4 weeks, +9.64% over 6 months (prices as of 9 Oct 2026). Valdrans Insider Activity Signal: Negative — 0 buys vs 10 sells disclosed in the last 90 days.
- Last close (9 Oct 2026)
- $261.44
- Today
- +1.93%
- 1 week
- +2.11%
- 4 weeks
- -1.56%
- 6 months
- +9.64%
- Insider signal
- Negative
- Latest coverage
- JNJ Q3 2026: filings, holdings, and macro context
$261.44USD
+1.93% today
1 week+2.11%
4 weeks-1.56%
6 months+9.64%
Coverage of JNJ(8)
JNJ Q3 2026: filings, holdings, and macro context
JNJ Q3 2026: filings, holdings, and macro context
JNJ Q3 2026 update — filings and holdings
JNJ Q2 2026: filings, holdings, and macro context
JNJ Q2 2026 update — filings, holdings, and macro context
JNJ Q2 2026 update — filings, holdings, and macro context
J&J agrees $5.5bn settlement to resolve talc cancer lawsuits
Johnson & Johnson will pay $5.5 billion to settle roughly 69,000 US lawsuits alleging its talc products caused ovarian cancer, covering 99.75% of remaining claims.